Stroke, Vol 24, 1725-1728, Copyright © 1993 by American Heart Association
K Hiramatsu, NF Kassell and KS Lee
BACKGROUND AND PURPOSE: Among the various calcium-induced biologic events
occurring in hypoxic neurons, activation of the calcium- activated neutral
proteinase (calpain) is a likely mediator of neuronal degeneration. In this
study, we assessed the protective effects of a calpain inhibitor
(Cbz-Val-Phe-H) against hypoxic damage to the neocortex. METHODS: An in
vitro neocortical slice model from gerbils was used to study the delay to
hypoxic depolarization during hypoxia and the recovery of synaptic
responses after hypoxia. These responses were examined in control slices
and slices treated with Cbz-Val-Phe-H. RESULTS: The delay to hypoxic
depolarization did not differ between treated and control groups. In
contrast, synaptic recovery after a fixed period of hypoxia (15 minutes)
was significantly improved in the Cbz-Val-Phe-H-treated slices (P <
.01). Concentrations of Cbz-Val-Phe-H of 50 mumol/L or greater were
significantly more protective than a concentration of 20 mumol/L (P <
.01). CONCLUSIONS: The data indicate that calcium-activated proteolysis
plays a critical role in hypoxic damage to the neocortex and that calpain
inhibitors may be useful therapeutic agents.
ARTICLES
Improved posthypoxic recovery of synaptic transmission in gerbil neocortical slices treated with a calpain inhibitor
Department of Neurological Surgery, University of Virginia, Health Sciences Center, Charlottesville 22908.
This article has been cited by other articles:
![]() |
N. Dourdin, A. K. Bhatt, P. Dutt, P. A. Greer, J. S. C. Arthur, J. S. Elce, and A. Huttenlocher Reduced Cell Migration and Disruption of the Actin Cytoskeleton in Calpain-deficient Embryonic Fibroblasts J. Biol. Chem., December 14, 2001; 276(51): 48382 - 48388. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Markgraf, N. L. Velayo, M. P. Johnson, D. R. McCarty, S. Medhi, J. R. Koehl, P. A. Chmielewski, M. D. Linnik, and J. A. Clemens Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in Rats • Editorial Comment Stroke, January 1, 1998; 29(1): 152 - 158. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |